Pharvaris (PHVS) Dividends Paid - Common Growth (1y) (2021 - 2026)
Pharvaris (PHVS) Dividends Paid - Common Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -10.39% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Pharvaris | 2.29 Bn | 1.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.22% |
| Dec 31, 2025 | 13.18% |
| Sep 30, 2025 | 459.76% |
| Jun 30, 2025 | -56.71% |
| Mar 31, 2025 | -37.83% |
| Dec 31, 2024 | -28.73% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | -100.00% |
| Mar 31, 2024 | 175.79% |
| Dec 31, 2023 | 154.94% |
| Sep 30, 2023 | -5,295,053,077.99% |
| Jun 30, 2023 | 2,767,120,105.74% |
| Mar 31, 2023 | -33.63% |
| Dec 31, 2022 | -31.06% |
| Sep 30, 2022 | 45.41% |
| Jun 30, 2022 | 141.81% |
| Mar 31, 2022 | -23.96% |
| Sep 30, 2021 | -120.92% |
| Jun 30, 2021 | -320.32% |
| Mar 31, 2021 | 1,348.99% |